Additionally, some other properties of apoptin make it more attractive for tumor gene therapy, including the ability to induce tumor-specific apoptosis independently of p53 [14] which is deficient in many cancers that are resistant to chemotherapeutic agent. This evidence concerns the gene TP53 and neoplasm.